Trial Profile
Clinical Trials Insight: 700058183
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Aug 2010
Price :
$35
*
At a glance
- Drugs Usistapide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Janssen Research & Development
- 06 Aug 2010 New trial record
- 11 Jul 2010 Part II results (n=60) presented at the 11th Congress on Obesity.